Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
Go back to Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 321.87 +1.16 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $320.71 | 52 Week High | $141.32 | |||
| Open | $321.95 | 52 Week Low | $97.79 | |||
| Day High | $323.84 | P/E | 51.50 | |||
| Day Low | $318.94 | EPS | $6.25 | |||
| Volume | 155,649 | |||||
